MPX Australia Pty Ltd

MPX International is a Canadian company based out of Ontario, Canada with a local Australian branch in Melbourne. They cultivate and manufacture medical-grade cannabis products with the focus of international distribution.

MPX International is a Canadian company based out of Ontario, Canada with a local Australian branch in Melbourne. They cultivate and manufacture medical-grade cannabis products with the focus of international distribution.

We researched MPX’s presence in Australia, and we found that:

MPX was granted a license to cultivate, manufacture, produce and distribute medicinal cannabis in Australia in November of 2019. This is kickstarted MPX’s plans to build their cannabis facility and start production. They are setting up a facility in Tasmania with the full support of the local government (Launceston council) and Tasmanian state government.

“We chose Australia, and specifically the island state of Tasmania, because of its reputation for producing high-quality organic products using clean energy, the availability of qualified technical staff, and the positive support from local government.” said Scott Boyes, Chairman, CEO of MPX International (Canada)

They are planning to have a 70,000 sq. ft. Building that will allow them to cultivate and grow cannabis indoors. MPX Australia is expecting to pay upwards of AU$4 million to build this facility and an additional AU$3-4 million for the infrastructure and equipment required to cultivate, manufacture and distribute medicinal cannabis.

MPX has a history of growing cannabis in their indoor facilities and on multi-hectare outdoor farms](http://mpxinternationalcorp.com/){:target=”_blank”}. Utilising Tasmania as one of the world’s best environments for the cultivation of cannabis (sun, soil and water), they can produce healthy cannabis for medical use.

Utilising their parent company’s experience, network and cannabis extraction methods, MPX Australia is looking to lead in the production of Cannabis and distribution across Australia, New Zealand and Asia. They are focused on creating the safest and healthiest cannabis plants for medical production - as this is highly sought after in emerging Asian markets. Australian wine, cosmetics and food are highly sought after due to its quality and quality guarantee.

They are expected to start prooduction by mid-2020 in Launceston.

MPX International is expanding its reaches internationally with its facility in Tasmania, Australia and acquisition of Swiss Premium Organic Cannabis Company (Holyweed). The choice to establish themselves in Tasmania and acquiring one of the worlds healthiest organic cannabis companies is a clear indication that they are looking to secure a piece of the international cannabis market as the “healthier choice” of cannabis products.

MPX produces medical cannabis products such as:

MPX licenses from the Australian government:

Company Information
Type: Manufacturer & Importer
Products: CBD and THC Oils
Capacity: 5,000 kg per annum
Opened: 2018
CEO & Co-founder: Scott Boyes
Employees: 30
Revenue: $6M (International)
Website: http://mpxinternationalcorp.com/
Phone: 0413 623 362
Email: info@mpxinternationalcorp.com
Address: Melbourne, VIC, 3000


View More Companies



James King

James is an experienced writer and legal cannabis advocate in Australia. He answers all the questions about business, legalisation and medicinal cannabis.

Disclaimer: Cannabis Place are not doctors and we recommend consulting health professionals for accurate information. This site may contain information regarding drugs. This medicinal cannabis content is designed for an 18+ audience. Click here for our full disclaimer